- Home
- CLDX vs DNUT Comparison
CLDX vs DNUT Comparison
Compare CLDX & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- DNUT
- Stock Information
- Founded
- CLDX 1983
- DNUT 1937
- Country
- CLDX United States
- DNUT United States
- Employees
- CLDX N/A
- DNUT N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- DNUT Food Chains
- Sector
- CLDX Health Care
- DNUT Consumer Staples
- Exchange
- CLDX Nasdaq
- DNUT Nasdaq
- Market Cap
- CLDX 1.7B
- DNUT 1.9B
- IPO Year
- CLDX 2008
- DNUT 2021
- Fundamental
- Price
- CLDX $20.14
- DNUT $5.35
- Analyst Decision
- CLDX Buy
- DNUT Buy
- Analyst Count
- CLDX 7
- DNUT 9
- Target Price
- CLDX $55.67
- DNUT $13.11
- AVG Volume (30 Days)
- CLDX 714.4K
- DNUT 4.8M
- Earning Date
- CLDX 05-05-2025
- DNUT 05-08-2025
- Dividend Yield
- CLDX N/A
- DNUT 2.99%
- EPS Growth
- CLDX N/A
- DNUT N/A
- EPS
- CLDX N/A
- DNUT 0.02
- Revenue
- CLDX $7,020,000.00
- DNUT $1,665,397,000.00
- Revenue This Year
- CLDX N/A
- DNUT $1.24
- Revenue Next Year
- CLDX $27.01
- DNUT $12.40
- P/E Ratio
- CLDX N/A
- DNUT $298.10
- Revenue Growth
- CLDX 1.99
- DNUT N/A
- 52 Week Low
- CLDX $18.61
- DNUT $5.31
- 52 Week High
- CLDX $47.00
- DNUT $17.84
- Technical
- Relative Strength Index (RSI)
- CLDX 41.83
- DNUT 25.90
- Support Level
- CLDX $18.95
- DNUT $5.31
- Resistance Level
- CLDX $21.85
- DNUT $6.32
- Average True Range (ATR)
- CLDX 1.39
- DNUT 0.46
- MACD
- CLDX 0.08
- DNUT -0.11
- Stochastic Oscillator
- CLDX 38.64
- DNUT 1.14
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S., includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line; International includes operations in the U.K., Ireland, Australia, New Zealand, and Mexico; and Market Development includes franchise operations across the globe, as well as operations in Japan. It derives maximum revenue from U.S. Segment.